-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
NORTHLAND Obtains Another Trademark Registration Certificate
On October 20, 2017, the company’s trademark application for the word-and-graphic mark “NORTHLAND N NORTHLAND,” which includes both text and a graphic element, received the Trademark Registration Certificate approved and issued by the Trademark Office of the State Administration for Industry and Commerce. The designated goods/services categories (international classifications: 5; 10; 35; 42; 44) are covered, and the registration is valid from June 28, 2017, to June 27, 2027.
As of now, the company holds a total of four trademark registration certificates. The successful registration of these trademarks will help safeguard the company’s corporate name and strengthen the protection of its registered trademarks, thereby preventing potential trademark infringement incidents and having a positive impact on the company’s future development.
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005